Below, I have pulled together the best apps for GLP-1 users across 6 categories, from all-in-one companions to mindset tools, based on what they actually do and who they are best suited for
Key Summary The patent for semaglutide will expire in 10 countries this year, but the UK patent will remain till 2031
Zenovatide Injectable GLP-1 Semaglutide Once-weekly injection for maximum potency Supports appetite control & sustainable fat loss Personalized ingredients to help you feel your best
Of the 4,321 people in the study on GLP-1 medications, there were 222 hospitalizations for alcohol use, or 5% of patients, significantly lower than the 30,198, or 40%, of patients who were hospitalized while using medications approved to treat alcohol use disorder